MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 227 filers reported holding MYRIAD GENETICS INC in Q3 2016. The put-call ratio across all filers is 1.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $1,000 | -90.9% | 47 | -91.4% | 0.00% | -88.9% |
| Q1 2017 | $11,000 | -87.1% | 547 | -89.3% | 0.01% | -74.3% |
| Q4 2016 | $85,000 | -60.3% | 5,105 | -50.9% | 0.04% | -75.4% |
| Q3 2016 | $214,000 | +32.1% | 10,400 | +96.2% | 0.14% | +18.3% |
| Q2 2016 | $162,000 | +48.6% | 5,300 | +82.8% | 0.12% | +57.9% |
| Q1 2016 | $109,000 | – | 2,900 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SCOPIA CAPITAL MANAGEMENT LP | 6,459,139 | $278,776,000 | 5.53% |
| Tieton Capital Management, LLC | 119,290 | $5,149,000 | 4.04% |
| RPg Family Wealth Advisory, LLC | 97,202 | $4,195,238,000 | 3.85% |
| RK Capital | 384,900 | $16,612,000 | 2.90% |
| Contrarius Investment Management Ltd | 652,288 | $28,153,000 | 2.65% |
| S&T BANK/PA | 331,885 | $14,324,000 | 2.22% |
| Euclidean Technologies Management, LLC | 40,917 | $1,766,000 | 1.90% |
| AIMZ Investment Advisors, LLC | 45,635 | $1,970,000 | 1.80% |
| Taylor Frigon Capital Management LLC | 34,783 | $1,486,000 | 1.67% |
| KILLEN GROUP INC | 366,305 | $15,810,000 | 1.63% |